Characteristics of incidentally discovered thyroid cancer

JAMA Otolaryngology - Head and Neck Surgery

Volumn 139, Issue 11, 2013, Pages 1181-1186

  Yoo, Frederick ^a   Chaikhoutdinov, Irina ^a   Mitzner, Ron ^a   Liao, Jason ^a   Goldenberg, David ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SIZE; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISTANT METASTASIS; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; INCIDENTAL FINDING; INCIDENTALLY DISCOVERED THYROID CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; THORAX RADIOGRAPHY; THYROID CANCER; TUMOR INVASION;

ADULT; AGE FACTORS; FEMALE; HUMANS; INCIDENCE; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; NEOPLASM STAGING; PENNSYLVANIA; PROGNOSIS; RETROSPECTIVE STUDIES; SEX FACTORS; THYROID NEOPLASMS;

EID: 84892384794     PISSN: 21686181     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaoto.2013.5050     Document Type: Article

References (28)

1. Howlader N, Noone A, Krapcho M, et al, eds. SEER Cancer Statistics Review. Bethesda, MD: National Cancer Institute; 2012. http://seer.cancer.gov/ csr/1975-2009-pops09/. Accessed January 23, 2013.
2. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2164-2167.
3. Morris LGT, Myssiorek D. Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis. Am J Surg. 2010;200(4):454-461.
4. Chen AY, Jemal A, Ward EM. Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer. 2009;115(16):3801-3807.
5. Enewold L, Zhu K, Ron E, et al. Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev. 2009;18(3):784-791.
6. Aschebrook-Kilfoy B,Ward MH, Sabra MM, Devesa SS. Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid. 2011;21(2):125-134.
7. Yoon DY, Chang SK, Choi CS, et al. The prevalence and significance of incidental thyroid nodules identified on computed tomography. J Comput Assist Tomogr. 2008;32(5):810-815.
8. Jin J, Wilhelm SM, McHenry CR. Incidental thyroid nodule: patterns of diagnosis and rate of malignancy. Am J Surg. 2009;197(3):320-324.
9. King DL, Stack BC Jr, Spring PM,Walker R, Bodenner DL. Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas. Otolaryngol Head Neck Surg. 2007;137(3):400-404.
10. Katz SC, Shaha A. PET-associated incidental neoplasms of the thyroid. J AmColl Surg. 2008;207(2):259-264.
11. Dean DS, Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab. 2008;22(6):901-911.
12. Jin J, McHenry CR. Thyroid incidentaloma. Best Pract Res Clin Endocrinol Metab. 2012;26(1):83-96.
13. Shetty SK, Maher MM, Hahn PF, Halpern EF, Aquino SL. Significance of incidental thyroid lesions detected on CT: correlation among CT, sonography, and pathology. AJR AmJ Roentgenol. 2006;187(5):1349-1356.
14. Kim K, Emoto N, Mishina M, et al. Incidental detection of thyroid nodules at magnetic resonance imaging of the cervical spine. Neurol Med Chir (Tokyo). 2013;53(2):77-81.
15. Van den Bruel A, Maes A, De Potter T, et al. Clinical relevance of thyroid fluorodeoxyglucose- whole body positron emission tomography incidentaloma. J Clin Endocrinol Metab. 2002;87(4):1517-1520.
16. Cohen MS, Arslan N, Dehdashti F, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery. 2001;130(6):941-946.
17. Datta RV, Petrelli NJ, Ramzy J. Evaluation and management of incidentally discovered thyroid nodules. Surg Oncol. 2006;15(1):33-42.
18. Minuto MN, MiccoliM, Viola D, et al. Incidental vs clinically evident thyroid cancer: a 5-year follow-up study. Head Neck. 2013;35(3):408-412.
19. Barbaro D, Simi U, Meucci G, Lapi P, Orsini P, Pasquini C. Thyroid papillary cancers: microcarcinoma and carcinoma, incidental cancers and non-incidental cancers-are they different diseases? Clin Endocrinol (Oxf). 2005;63(5):577-581.
20. Sciuto R, Romano L, Rea S, Marandino F, Sperduti I, Maini CL. Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution. Ann Oncol. 2009;20(10):1728-1735.
21. Dean DS, Hay ID. Prognostic indicators in differentiated thyroid carcinoma. Cancer Control. 2000;7(3):229-239.
22. Verburg FA, Mäder U, Tanase K, et al. Life expectancy is reduced in differentiated thyroid cancer patients ≥45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients. J Clin Endocrinol Metab. 2013;98(1):172-180.
23. Rahbari R, Zhang L, Kebebew E. Thyroid cancer gender disparity. Future Oncol. 2010;6(11):1771-1779.
24. Owens GM. Gender differences in health care expenditures, resource utilization, and quality of care. J Manag Care Pharm. 2008;14(3)(suppl):2-6.
25. Hsieh S-H, Chen S-T, Hsueh C, Chao T-C, Lin J-D. Gender-specific variation in the prognosis of papillary thyroid cancer TNM stages II to IV. Int J Endocrinol. 2012;2012:379097.
26. Kahn C, Simonella L, Sywak M, Boyages S, Ung O, O'Connell D. Pathways to the diagnosis of thyroid cancer in New SouthWales: a population-based cross-sectional study. Cancer Causes Control. 2012;23(1):35-44.
27. Davies L, Ouellette M, Hunter M,Welch HG. The increasing incidence of small thyroid cancers: where are the cases coming from? Laryngoscope. 2010;120(12):2446-2451.
28. Bhargavan M, Sunshine JH. Utilization of radiology services in the United States: levels and trends in modalities, regions, and populations. Radiology. 2005;234(3):824-832.